Bath & Body Works, Inc. (NYSE:BBWI) Shares Purchased by Lecap Asset Management Ltd.

Lecap Asset Management Ltd. raised its position in Bath & Body Works, Inc. (NYSE:BBWI) by 16.2% during the 3rd quarter, Holdings Channel reports. The firm owned 120,863 shares of the company’s stock after acquiring an additional 16,830 shares during the quarter. Bath & Body Works comprises about 0.8% of Lecap Asset Management Ltd.’s holdings, making the stock its 16th biggest position. Lecap Asset Management Ltd.’s holdings in Bath & Body Works were worth $3,858,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Sequoia Financial Advisors LLC raised its position in shares of Bath & Body Works by 14.9% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 6,514 shares of the company’s stock worth $208,000 after purchasing an additional 847 shares during the last quarter. Everett Harris & Co. CA lifted its position in shares of Bath & Body Works by 1.5% in the third quarter. Everett Harris & Co. CA now owns 49,140 shares of the company’s stock valued at $1,569,000 after acquiring an additional 725 shares in the last quarter. Raymond James & Associates lifted its position in shares of Bath & Body Works by 6.8% in the third quarter. Raymond James & Associates now owns 89,680 shares of the company’s stock valued at $2,863,000 after acquiring an additional 5,706 shares in the last quarter. Blue Trust Inc. boosted its stake in shares of Bath & Body Works by 54.0% during the third quarter. Blue Trust Inc. now owns 4,262 shares of the company’s stock valued at $136,000 after acquiring an additional 1,495 shares during the last quarter. Finally, Hengehold Capital Management LLC increased its position in Bath & Body Works by 26.1% during the 3rd quarter. Hengehold Capital Management LLC now owns 32,300 shares of the company’s stock worth $1,031,000 after purchasing an additional 6,690 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have issued reports on BBWI shares. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Bath & Body Works from $57.00 to $54.00 and set a “buy” rating on the stock in a report on Monday, August 26th. BMO Capital Markets restated an “outperform” rating and set a $50.00 target price (down previously from $52.00) on shares of Bath & Body Works in a research report on Thursday, August 29th. JPMorgan Chase & Co. cut their price target on Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating for the company in a report on Thursday, August 29th. Raymond James reduced their price target on Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating on the stock in a research note on Thursday, August 29th. Finally, UBS Group lowered their price objective on Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating for the company in a research report on Thursday, August 29th. Eight investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $42.35.

Insiders Place Their Bets

In related news, CEO Gina Boswell bought 6,000 shares of the stock in a transaction dated Wednesday, October 9th. The stock was acquired at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the completion of the purchase, the chief executive officer now owns 242,987 shares in the company, valued at $7,202,134.68. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.27% of the stock is currently owned by insiders.

Bath & Body Works Stock Performance

BBWI opened at $29.82 on Wednesday. Bath & Body Works, Inc. has a 1 year low of $26.20 and a 1 year high of $52.99. The firm has a 50 day moving average price of $30.91 and a 200 day moving average price of $38.34. The company has a market cap of $6.66 billion, a PE ratio of 7.69, a price-to-earnings-growth ratio of 0.94 and a beta of 1.77.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The company had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.54 billion. On average, sell-side analysts predict that Bath & Body Works, Inc. will post 3.18 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 6th. Shareholders of record on Friday, August 23rd were given a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 2.68%. The ex-dividend date was Friday, August 23rd. Bath & Body Works’s dividend payout ratio (DPR) is presently 20.62%.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.